Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat in Advanced Adenoid Cystic Carcinoma
NCT01175980Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2010
- Primary completion
- Jun 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vorinostat in adenoid cystic carcinoma (ACC), sponsored by National Cancer Institute. Started Aug 2010; status: completed.
02
Drugs
vorinostat
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT01175980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175980.